Magazine Article | May 2, 2022

Biologic And Small Molecule Drug Substance CDMO Selection Metrics Align

Source: Life Science Leader

By Industry Standard Research

ISR’s annual CDMO Benchmarking research asks participants to identify the CDMO attributes that factor into their service provider selection decision. Four out of five of the top metrics sync up among drug substance outsourcers for biologics and small molecules. However, among large molecule outsourcers, a Track record for meeting quality performance metrics made the top five but landed in 8th position among small molecule outsourcers. Conversely, small molecule outsourcers prized a Proven ability to manufacture small molecule API while this attribute ranked 6th for biologic outsourcers.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader